- Investing Ideas
- Global Pharmaceuticals & Biotech High Return On Equity, Low Debt
Global Pharmaceuticals & Biotech High Return On Equity, Low Debt
Results
49
Stocks with a return on equity of over 30% and a debt to equity ratio below 1.
49 companies
Roche Holding
Market Cap: CHF 258.9b
Engages in the pharmaceuticals and diagnostics businesses in Europe, North America, Latin America, Asia, Africa, Australia, and New Zealand.
ROP
CHF 324.60
7D
-1.3%
1Y
21.3%
Gilead Sciences
Market Cap: US$160.2b
A biopharmaceutical company, discovers, develops, and commercializes medicines in the areas of unmet medical need in the United States, Europe, and internationally.
GILD
US$129.18
7D
-5.2%
1Y
16.9%
Illumina
Market Cap: US$25.9b
Provides sequencing- and array-based solutions for genetic and genomic analysis in the Americas, Europe, Greater China, the Asia Pacific, the Middle East, and Africa.
ILMN
US$168.06
7D
5.9%
1Y
104.3%
Exelixis
Market Cap: US$13.0b
An oncology company, focuses on the discovery, development, and commercialization of new medicines for difficult-to-treat cancers in the United States.
EXEL
US$52.49
7D
2.0%
1Y
23.9%
Orion Oyj
Market Cap: €9.7b
Develops, manufactures, and markets human and veterinary pharmaceuticals and active pharmaceutical ingredients (APIs) in Finland, Scandinavia, rest of Europe, North America, and internationally.
ORNBV
€69.15
7D
-2.5%
1Y
10.9%
RemeGen
Market Cap: HK$58.3b
A biopharmaceutical company, discovers, develops, produces, and commercializes biological drugs for the treatment of autoimmune, oncology, and ophthalmic diseases in Mainland China and the United States.
9995
HK$70.50
7D
-14.7%
1Y
53.3%
Abbott India
Market Cap: ₹549.0b
Operates as a pharmaceutical company in India.
500488
₹26,017.70
7D
-3.2%
1Y
-18.1%
Shanghai Allist Pharmaceuticals
Market Cap: CN¥37.5b
A pharmaceutical company, engages in the research and development of tumor-targeted drugs in China in internationally.
688578
CN¥84.29
7D
-6.1%
1Y
-10.6%
Sunshine Guojian Pharmaceutical (Shanghai)
Market Cap: CN¥35.2b
A biopharmaceutical company, engages in the research and development, production, and sale of antibody drugs.
688336
CN¥55.19
7D
-14.4%
1Y
-11.3%
SK Biopharmaceuticals
Market Cap: ₩7.1t
A pharmaceutical company, engages in the research, development, and commercialization of drugs for the treatment of central nervous system disorders.
A326030
₩88,300.00
7D
-1.6%
1Y
-2.3%
Sumitomo Pharma
Market Cap: JP¥634.5b
Manufactures, purchases, and sells pharmaceutical products for medical treatment in Japan, North America, and Asia.
4506
JP¥1,435.50
7D
-11.6%
1Y
78.5%
GlaxoSmithKline Pharmaceuticals
Market Cap: ₹367.0b
Manufactures, distributes, and trades in pharmaceuticals in India and internationally.
500660
₹2,166.30
7D
-1.9%
1Y
-36.9%
ACADIA Pharmaceuticals
Market Cap: US$3.7b
A biopharmaceutical company, focuses on the development and commercialization of medicines for neurological and rare disease in North America.
ACAD
US$21.72
7D
0.4%
1Y
1.8%
Zealand Pharma
Market Cap: DKK 22.9b
A biotechnology company, engages in the discovery, development, and commercialization of peptide-based medicines in Denmark and the United States.
ZEAL
DKK 326.30
7D
0.8%
1Y
-30.0%
HUTCHMED (China)
Market Cap: UK£1.5b
HUTCHMED (China) Limited, together with its subsidiaries, discovers, develops, and commercializes targeted therapeutics and immunotherapies to treat cancer and immunological diseases in Hong Kong, the United States, and internationally.
HCM
UK£1.73
7D
-4.2%
1Y
-23.0%
Shenyang Xingqi PharmaceuticalLtd
Market Cap: CN¥13.1b
Engages in the research, development, production, and sale of ophthalmic drugs in the People’s Republic of China.
300573
CN¥36.95
7D
-3.9%
1Y
-1.2%
Pharma Mar
Market Cap: €1.6b
A biopharmaceutical company, focuses on the research, development, production, and commercialization of bio-active principles for the use in oncology in Spain, Germany, Ireland, France, Switzerland, rest of the European Union, the United States, and internationally.
PHM
€94.25
7D
-6.5%
1Y
2.6%
ADMA Biologics
Market Cap: US$1.8b
A biopharmaceutical company, develops, manufactures, and markets specialty plasma-derived biologics for the treatment of immune deficiencies and infectious diseases in the United States and internationally.
ADMA
US$7.98
7D
0.6%
1Y
-60.0%
Innoviva
Market Cap: US$1.6b
Operates as a biopharmaceutical company in the United States and internationally.
INVA
US$22.16
7D
1.2%
1Y
4.7%
Oscotec
Market Cap: ₩1.6t
Operates as a biotechnology company, engages in the drug development, functional materials and related products, and dental bone graft material businesses.
A039200
₩41,750.00
7D
-0.7%
1Y
48.6%
Center Laboratories
Market Cap: NT$28.7b
A pharmaceutical company, develops, manufactures, and sells pharmaceuticals in Taiwan and internationally.
4123
NT$38.85
7D
1.6%
1Y
1.5%
Theravance Biopharma
Market Cap: US$820.7m
A biopharmaceutical company, develops and commercializes medicines in the United States.
TBPH
US$16.37
7D
1.0%
1Y
52.0%
Basilea Pharmaceutica
Market Cap: CHF 617.9m
A Swiss commercial-stage biotech company focused on developing and commercializing treatments for severe bacterial and fungal infections.
BSLN
CHF 49.85
7D
-5.0%
1Y
1.3%
Sanofi India
Market Cap: ₹73.2b
Manufactures and trades in drugs and pharmaceutical products in India, Singapore and internationally.
500674
₹3,183.75
7D
2.5%
1Y
-48.3%
CorMedix
Market Cap: US$645.7m
A biopharmaceutical company, focuses on developing and commercializing therapeutic products for life-threatening diseases and conditions in the United States.
CRMD
US$8.54
7D
1.4%
1Y
-35.2%
Qyuns Therapeutics
Market Cap: HK$3.5b
A clinical-stage biotech company, engages in the research and development of biologic therapies for autoimmune and allergic diseases in China.
2509
HK$15.23
7D
-9.7%
1Y
2.9%
Abeona Therapeutics
Market Cap: US$323.2m
A commercial-stage biopharmaceutical company, develops gene and cell therapies for life-threatening diseases in the United States.
ABEO
US$5.82
7D
0.7%
1Y
-10.2%
Fidson Healthcare
Market Cap: ₦327.6b
Manufactures and distributes pharmaceutical products in Nigeria.
FIDSON
₦136.50
7D
0%
1Y
329.2%
Compugen
Market Cap: US$207.1m
A clinical-stage therapeutic discovery and development company, engages in the research, development, and commercialization of therapeutics and product candidates in Israel, the United States, and Europe.
CGEN
US$2.22
7D
-20.1%
1Y
29.8%
Saniona
Market Cap: SEK 1.9b
A clinical-stage biopharmaceutical company, focuses on discovering, developing, and delivering innovative treatments for neurological and psychiatric disorders in Ireland, the United States, Germany, Denmark, and the United Kingdom.
SANION
SEK 13.60
7D
-11.4%
1Y
46.2%
Oramed Pharmaceuticals
Market Cap: US$149.4m
Engages in the research and development of pharmaceutical solutions with a technology platform for the oral delivery of therapeutic proteins.
ORMP
US$3.81
7D
-3.8%
1Y
77.2%
Vaxart
Market Cap: US$145.2m
A clinical-stage biotechnology company, discovers and develops oral recombinant protein vaccines based on its vector-adjuvant-antigen standardized technology proprietary oral vaccine platform.
VXRT
US$0.62
7D
-6.8%
1Y
55.9%
Bioxyne
Market Cap: AU$197.5m
Manufactures and distributes therapeutic goods, and health and wellness products in Australia, the United States, the United Kingdom, Czechia, Switzerland, France, Germany, and Japan.
BXN
AU$0.086
7D
7.5%
1Y
244.0%
Hoechst Pakistan
Market Cap: PK₨38.7b
Together with its subsidiary, manufactures, sells, and trades in pharmaceutical and related products in Pakistan, Afghanistan, and internationally.
HPL
PK₨4,052.50
7D
0.6%
1Y
26.1%
Quality Chemical Industries
Market Cap: USh522.2b
Manufactures and sells pharmaceutical drugs in Uganda.
QCIL
USh143.00
7D
0.7%
1Y
60.7%
NATURLAND Holding Vagyonkezelo es Befektetesi Nyilvanosan Mukodo Reszvenytarsasag
Market Cap: Ft39.0b
Manufactures and sells pharmaceutical products in Hungary.
NATURLAND
Ft2,820.00
7D
0%
1Y
6.8%